157 related articles for article (PubMed ID: 32353704)
1. Lymphoma in the setting of autoimmune diseases: A review of association and mechanisms.
Khanmohammadi S; Shabani M; Tabary M; Rayzan E; Rezaei N
Crit Rev Oncol Hematol; 2020 Jun; 150():102945. PubMed ID: 32353704
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary B-cell non-Hodgkin's lymphoma associated with autoimmune disorders: a clinicopathological review of six cases.
Nicholson AG; Wotherspoon AC; Jones AL; Sheppard MN; Isaacson PG; Corrin B
Eur Respir J; 1996 Oct; 9(10):2022-5. PubMed ID: 8902461
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of autoimmune disease-related non-Hodgkin lymphoma: a Korean single-center, retrospective clinical study.
Jeon YW; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
Korean J Intern Med; 2016 Sep; 31(5):944-52. PubMed ID: 27384438
[TBL] [Abstract][Full Text] [Related]
5. Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.
Poppema S; Maggio E; van den Berg A
Leuk Lymphoma; 2004 Mar; 45(3):423-31. PubMed ID: 15160902
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
Smedby KE; Askling J; Mariette X; Baecklund E
J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune diseases and malignant lymphoma].
Müller-Hermelink HK; Greiner A
Verh Dtsch Ges Pathol; 1992; 76():96-109. PubMed ID: 1283281
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
Baecklund E; Smedby KE; Sutton LA; Askling J; Rosenquist R
Semin Cancer Biol; 2014 Feb; 24():61-70. PubMed ID: 24333759
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity and hematologic malignancies: associations and mechanisms.
Martin DN; Mikhail IS; Landgren O
Leuk Lymphoma; 2009 Apr; 50(4):541-50. PubMed ID: 19373651
[TBL] [Abstract][Full Text] [Related]
10. The dual association between lymphoma and autoimmunity.
Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
[TBL] [Abstract][Full Text] [Related]
11. DAB(389)IL-2 (denileukin diftitox, ONTAK): other potential applications.
LeMaistre CF
Clin Lymphoma; 2000 Nov; 1 Suppl 1():S37-40. PubMed ID: 11707862
[TBL] [Abstract][Full Text] [Related]
12. [Malignant lymphoma occurring subsequent to autoimmune disease].
Matsunaga T; Maseki N; Kaneko Y; Sampi K; Tsuchimochi T; Sakurai M; Hattori M; Takayama S
Rinsho Ketsueki; 1992 Jun; 33(6):829-33. PubMed ID: 1433925
[TBL] [Abstract][Full Text] [Related]
13. Causes and consequences of the autoimmune lymphoproliferative syndrome.
Rao VK; Straus SE
Hematology; 2006 Feb; 11(1):15-23. PubMed ID: 16522544
[TBL] [Abstract][Full Text] [Related]
14. Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome.
Boulanger E; Rieux-Laucat F; Picard C; Legall M; Sigaux F; Clauvel JP; Oksenhendler E; Le Deist F; Meignin V
Br J Haematol; 2001 May; 113(2):432-4. PubMed ID: 11380411
[TBL] [Abstract][Full Text] [Related]
15. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy.
Gutiérrez-Saborido D; Gutiérrez-Valencia A; González Domenech CM; López Ruz MÁ; Raffo Márquez M; Omar M; Girón-González JA;
Ann Hematol; 2019 Aug; 98(8):1953-1959. PubMed ID: 31025161
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?
Yadlapati S; Efthimiou P
Biomed Res Int; 2016; 2016():8631061. PubMed ID: 27429984
[TBL] [Abstract][Full Text] [Related]
17. Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases.
Wöhrer S; Troch M; Zwerina J; Schett G; Skrabs C; Gaiger A; Jaeger U; Zielinski CC; Raderer M
Ann Oncol; 2007 Apr; 18(4):647-51. PubMed ID: 17218490
[TBL] [Abstract][Full Text] [Related]
18. The development of lymphomas in mice with autoimmune disorders treated with azathioprine.
Casey TP
Blood; 1968 Mar; 31(3):396-9. PubMed ID: 5640634
[No Abstract] [Full Text] [Related]
19. Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.
Janić MD; Brasanac CD; Janković JS; Dokmanović BL; Krstovski RN; Kraguljac Kurtović JN
Pediatr Blood Cancer; 2009 Dec; 53(6):1117-9. PubMed ID: 19588524
[TBL] [Abstract][Full Text] [Related]
20. Lymphoma complicating immunodeficiency disorders.
Levine AM
Ann Oncol; 1994; 5 Suppl 2():29-35. PubMed ID: 8204517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
